Skip to main content

GOLDMAN SACHS GROUP INC

Position in CRDF — Cardiff Oncology, Inc.

CIK 886982 NEW YORK, NY

Position in CRDF

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$219,668
-$862,423 QoQ
Shares Held
135,598
-64.8% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. CRDF ranks #319 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRDF

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $219,668 135,598
2025-12-31 $1,082,091 385,086
2025-09-30 $936,735 454,726
2025-06-30 $240,451 76,334
2025-03-31 $336,397 107,133
2024-12-31 $664,167 153,034
2024-09-30 $250,929 93,981
2024-06-30 $339,353 152,862
2024-03-31 $1,526,567 285,874
2022-09-30 $22,097 14,349
2022-06-30 $92,074 41,852
2022-03-31 $860,676 347,047
2021-12-31 $2,224,469 370,128
2021-09-30 $2,382,095 357,672
2021-06-30 $548,764 82,521
2021-03-31 $586,871 63,377